NMD Pharma Announces FDA Orphan Drug Designation Granted to NMD670 for the Treatment of Patients with Charcot-Marie-Tooth Disease

Published on January 6, 2025

€155 million from investors including Novo Holdings, Lundbeckfonden BioCapital, INKEF Capital, Roche Venture Fund, and Jeito Capital. Find

Continue reading on website
Other news

Tourism Authority of Thailand joins Harbin Ice and Snow Festival

January 6, 2025
visual journey showcasing Thailand’s rich cultural heritage, unique traditions, and vibrant tourism experiences.Through the lens of the 5

Using SIP Calculators to Plan Your SIP Investments Strategically

January 6, 2025
tool an investor can use to plan and manage their mutual fund investment through a systematic investment plan (SIP).What is a SIP